All Reports Events Blogs Videos
Showing 222 results
  • NEW
    Blog
    Aug. 03, 2026

    In Part 1 of this series, Why the Migration Clock Has Already Started, we explained why Banking, Financial Services and Insurance (BFSI) enterprises cannot wait for a formal mandate to begin their Post-quantum Cryptography (PQC) migration and estimated a roughly US$7 billion spending opportunity across the top…
  • Blog
    July 29, 2026

    The pharmaceutical technology market is moving beyond point solutions. For years, providers competed by solving specific problems within individual parts of the value chain. Today, differentiation increasingly depends on how well those solutions can understand context,…
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Blog
    July 14, 2026

    Life Sciences commercial teams have a familiar problem: every few years, the industry finds a new way to create fragmentation.  First came Customer Relationship Management (CRM) add-ons. Then omnichannel tools, content platforms, analytics dashboards, field enablement systems, event platforms,…
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • Blog
    June 09, 2026

    For years, life sciences commercial technology providers sold nouns. Customer Relationship Management (CRM). Analytics. Content. Events. Patient engagement. Next-best-action. Learning. Field enablement.  Each category had its own buyer, its own implementation partner, its own operating model, and often its own dashboard.…
  • Roundtable
    April 16, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Thursday, May 07, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Roundtable
    March 31, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Tuesday, April 14, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Provider Compendium
    Feb. 11, 2026

    Enterprises across the payments value chain are accelerating modernization to meet real-time settlement demands, expand cross-border reach, and operate in increasingly data-rich ecosystems. ISO 20022 migration, rising regulatory scrutiny, and the need for resilient, interoperable architectures…
  • Provider Compendium
    Feb. 09, 2026

    The banking industry is entering a new phase of technology transformation, marked by focused execution, legacy systems modernization, and heightened regulatory expectations. As banks move beyond early digital initiatives, they are prioritizing operational resilience, simplification, and…
  • Blog
    Feb. 09, 2026

    Impact Sourcing is no longer a side note in corporate responsibility reports. With over 520,000 workers globally and growth of 4-5% year-over-year, the model has become a serious workforce strategy for enterprises facing talent shortages, inclusion gaps, and pressure to show real progress on equitable economic development.   As…
  • Feb. 04, 2026

    As the Veeva ecosystem continues to expand rapidly - now representing a market of nearly $2 billion- life sciences organizations are rethinking how they approach Veeva-enabled transformation. What was once focused primarily on implementation is evolving…
  • Video
    Feb. 03, 2026

    As Veeva becomes the cornerstone of strategic transformation in life sciences, expectations from service providers are rapidly evolving. In this Q&A session, Chunky Satija, Vice President, and Rohit K, Practice Director, from Everest Group, discuss the…
  • Market Insights™
    Jan. 19, 2026

  • Market Insights™
    Jan. 19, 2026

  • Market Insights™
    Jan. 19, 2026

Items per page